Literature DB >> 1040133

The development of ambiguous federal policy: early and periodic screening, diagnosis, and treatment (EPSDT).

A M Foltz.   

Abstract

This paper examines why Congress's first major program for comprehensive health care to needy children took five years to begin even partial operation. An examination of the 1967 program's legislative history reveals that Congress paid little attention to EPSDT's implications: it was left ambiguous whether health (Title V) or welfare (Title XIX) would administer; costs were never clearly stated; eligibility and scope of services to be provided were left vague. Despite pressure from welfare rights interest groups, these ambiguities delayed the preparation of regulation and guidelines which never did succeed in resolving the question of overlapping jurisdiction and costs. In addition, many states' resistance to paying for the program further held up implementation. The paper concluded that: (1) Congress's and HEW's unwillingness to face up to the real costs of health programs threatens long-term public and state support for such programs; (2) division of responsibility between health and welfare lessens the impact of a program; (3) grant-in-aid programs give states the power to distort the intent of federal health policies; and (4) where states fail to implement such policies, initiatives may pass to consumer advocacy groups.

Entities:  

Mesh:

Year:  1975        PMID: 1040133

Source DB:  PubMed          Journal:  Milbank Mem Fund Q Health Soc        ISSN: 0160-1997


  3 in total

1.  Is early and periodic screening, diagnosis, and treatment (EPSDT) worthwhile?

Authors:  R Currier
Journal:  Public Health Rep       Date:  1977 Nov-Dec       Impact factor: 2.792

2.  The long-term impacts of Medicaid exposure in early childhood: Evidence from the program's origin.

Authors:  Michel H Boudreaux; Ezra Golberstein; Donna D McAlpine
Journal:  J Health Econ       Date:  2015-11-19       Impact factor: 3.883

3.  EPSDT impact on health status.

Authors:  P H Irwin; R Conroy-Hughes
Journal:  Health Care Financ Rev       Date:  1981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.